For instance, a prospective study showed that elevated immunoglobulin G (IgG) was a significant predictor of hepatic decompensation in MASH patients [9], while immunoglobulin M (IgM) appeared to ameliorate chronic inflammation of the liver and insulin resistance [10,11]. The gene discussed is CD40LG; the disease is metabolic dysfunction-associated steatohepatitis.